Skip to main content

McKesson Corporation stock price and financials

  • MCK · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$1102.80+2.39%Close 13 Nov 2026
Market value
$127.9B
P/E
27.21
EV / EBITDA
17.72
Dividend yield
0.3%
Beta · 1 year
−0.18
Return · 1 year
+31.2%
52-week range$723.68 — $1121.50

Share price close 16 Nov 2026

+10.8%1 monthHigh $1106.26Low $960.56
$950$1,000$1,050$1,100$1,150Q2 FY2027 report filed 4 Nov 202623 Oct29 Oct4 Nov10 Nov16 Nov
+45.5%6 monthsHigh $1106.26Low $734.82
$700$800$900$1,000$1,100$1,200Q1 FY2027 report filed 5 Aug 2026Q2 FY2027 report filed 4 Nov 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+34.9%year to dateHigh $1106.26Low $725.17
$700$800$900$1,000$1,100$1,200Q3 FY2026 report filed 4 Feb 2026Q4 FY2026 report filed 8 May 2026Q1 FY2027 report filed 5 Aug 2026Q2 FY2027 report filed 4 Nov 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+31.4%1 yearHigh $1106.26Low $725.17
$700$800$900$1,000$1,100$1,200Q3 FY2026 report filed 4 Feb 2026Q4 FY2026 report filed 8 May 2026Q1 FY2027 report filed 5 Aug 2026Q2 FY2027 report filed 4 Nov 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+148%3 yearsHigh $1106.26Low $439.47
$400$600$800$1,000$1,200Q3 FY2024 report filed 8 Feb 2024Q4 FY2024 report filed 8 May 2024Q1 FY2025 report filed 7 Aug 2024Q2 FY2025 report filed 7 Nov 2024Q3 FY2025 report filed 6 Feb 2025Q4 FY2025 report filed 9 May 2025Q1 FY2026 report filed 6 Aug 2025Q2 FY2026 report filed 6 Nov 2025Q3 FY2026 report filed 4 Feb 2026Q4 FY2026 report filed 8 May 2026Q1 FY2027 report filed 5 Aug 2026Q2 FY2027 report filed 4 Nov 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+690%10 yearsHigh $1106.26Low $108.34
$0$250$500$750$1,000$1,250Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

McKesson Corporation reported revenue of $403.4 billion for fiscal year 2026 (the twelve months to 31 Mar 2026), up 12.4% from fiscal 2025. Net income was $4.76 billion and diluted earnings per share $38.38.

In its latest reported quarter, the second quarter of fiscal 2027 (the three months to 30 Sep 2026), revenue was $111.0 billion, up 7.6% from a year earlier.

Figures from McKesson Corporation's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.

Against Health Care

Growth
Top quarter
Revenue +11.1% a year over five years · 9th of 37
Profitability
Top quarter
Return on invested capital 21.2%, five-year average · 5th of 38
Balance sheet
Upper half
Net debt 0.6× EBITDA · 11th of 38
Valuation
Below the median
P/E 27.2 · 16th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2026
$403.4B+12.4%
Net income
$4.76B+44.5%
Diluted EPS
$38.38+49.2%
Gross margin
3.6%−0.1 pts
Free cash flow
$5.72B+3.1%
Net debt
$4.64B+173%

Fiscal 2026 against fiscal 2025; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2017–2026

  • Revenue
  • Net income
−$100B$0$100B$200B$300B$400B$500BRevenue, FY17: $198.53BNet income, FY17: $5.07BFY17Revenue, FY18: $208.36BNet income, FY18: $67MFY18Revenue, FY19: $214.32BNet income, FY19: $34MFY19Revenue, FY20: $231.05BNet income, FY20: $900MFY20Revenue, FY21: $238.23BNet income, FY21: −$4.54BFY21Revenue, FY22: $263.97BNet income, FY22: $1.11BFY22Revenue, FY23: $276.71BNet income, FY23: $3.56BFY23Revenue, FY24: $308.95BNet income, FY24: $3BFY24Revenue, FY25: $359.05BNet income, FY25: $3.29BFY25Revenue, FY26: $403.43BNet income, FY26: $4.76BFY26

Latest quarter · Q2 FY2027 to 30 Sep 2026, filed 4 Nov 2026 · Full results →

Revenue
$111.0B+7.6% on a year
Gross margin
3.6%+0.1 pts on a year
Operating income
$1.60B+14.0% on a year
Net income
$1.22B+9.7% on a year
Diluted EPS
$10.44+17.0% on a year
Free cash flow
$3.00B+29.9% on a year

Comparable companies All of Health Care →

McKesson Corporation beside the other S&P 500 members in Health Care Distributors, then the largest in Health Care, by market value.

McKesson Corporation and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
McKesson CorporationMCK$127.9B+2.4%+31.2%+8.2%1.1%27.2
CencoraCOR$68.14B+2.8%−1.2%+5.1%0.8%26.0
Cardinal HealthCAH$65.30B+1.1%+37.6%+10.0%0.7%35.9
Henry ScheinHSIC$9.29B+0.1%+18.4%+6.2%3.1%22.1
Eli LillyLLY$1.37T+1.1%+41.8%+45.5%31.9%49.6
Johnson & JohnsonJNJ$686.1B+0.8%+47.0%+7.8%16.2%42.6
AbbVieABBV$525.9B+0.2%+26.5%+10.7%15.7%51.1

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2017–2026

  • Gross
  • Operating
  • Net
-5%0%5%10%3.6%1.5%1.2%FY17FY20FY23FY26

McKesson Corporation revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By segment

McKesson Corporation revenue by segment, by fiscal year
RevenueFY 2024FY 2025FY 2026
North American Pharmaceutical$261.4B$304.5B+16.5%$336.7B+10.6%
Oncology & Multispecialty$30.49B$36.86B+20.9%$48.42B+31.4%
Medical-Surgical Solutions$11.31B$11.38B+0.6%$11.51B+1.1%
Prescription Technology Solutions$4.77B$5.22B+9.4%$5.80B+11.3%
Not allocated to a line$1.01B$1.09B+7.0%$1.04B−4.0%
Total revenue$309.0B$359.1B$403.4B

Financial statements

Fiscal years, the latest ending 31 Mar 2026. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

McKesson Corporation income statement, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Revenue$198.5B$208.4B$214.3B$231.1B$238.2B$264.0B$276.7B$309.0B$359.1B$403.4B
Revenue growth+4.0%+4.9%+2.9%+7.8%+3.1%+10.8%+4.8%+11.7%+16.2%+12.4%
Gross profit$11.27B$11.18B$11.75B$12.02B$12.15B$13.13B$12.36B$12.83B$13.32B$14.55B
Operating income$7.12B$762.0M$886.0M$2.49B−$5.04B$2.04B$4.38B$3.91B$4.42B$6.21B
Net income$5.07B$67.00M$34.00M$900.0M−$4.54B$1.11B$3.56B$3.00B$3.29B$4.76B
Diluted EPS$22.73$0.32$0.17$4.95−$28.26$7.23$25.03$22.39$25.72$38.38
Gross margin5.7%5.4%5.5%5.2%5.1%5.0%4.5%4.2%3.7%3.6%
Operating margin3.6%0.4%0.4%1.1%−2.1%0.8%1.6%1.3%1.2%1.5%
Net margin2.6%0.0%0.0%0.4%−1.9%0.4%1.3%1.0%0.9%1.2%

Cash flow

McKesson Corporation cash flow, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Operating cash flow$4.74B$4.34B$4.04B$4.37B$4.54B$4.43B$5.16B$4.31B$6.08B$6.16B
Capital expenditure$404.0M$405.0M$426.0M$362.0M$451.0M$388.0M$390.0M$431.0M$537.0M$436.0M
Free cash flow$4.34B$3.94B$3.61B$4.01B$4.09B$4.05B$4.77B$3.88B$5.55B$5.72B

Balance sheet and shares

McKesson Corporation balance sheet and shares, annual
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Cash and equivalents$2.78B$2.67B$2.98B$4.01B$6.28B$3.53B$4.68B$4.58B$5.69B$3.98B
Total debt$8.54B$7.88B$7.59B$9.40B$9.40B$7.54B$7.29B$7.39B$7.39B$8.61B
Shareholders' equity$11.10B$9.80B$8.09B$5.09B−$21.00M−$2.27B−$1.86B−$1.97B−$2.07B−$2.17B
Diluted shares223M209M197M182M161M154M142M134M128M124M
Dividends per share$1.12$1.30$1.51$1.62$1.67$1.83$2.09$2.40$2.75$3.17

Quarterly figures

The last eight fiscal quarters, the latest ending 30 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

McKesson Corporation quarterly financial figures
PeriodQ3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027Q2 FY2027
Revenue$95.29B$90.82B$97.83B$103.2B$106.2B$96.30B$105.4B$111.0B
Revenue, year on year+17.8%+18.9%+23.4%+10.1%+11.4%+6.0%+7.7%+7.6%
Gross margin3.4%4.0%3.4%3.4%3.5%4.2%3.5%3.6%
Operating income$1.22B$1.59B$1.04B$1.41B$1.62B$2.15B$1.32B$1.60B
Net income$879.0M$1.26B$784.0M$1.11B$1.19B$1.68B$614.0M$1.22B
Diluted EPS$6.95$10.00$6.25$8.92$9.59$13.69$5.15$10.44
Free cash flow−$2.51B$7.58B−$1.03B$2.31B$1.12B$3.31B−$332.0M$3.00B

Operating KPIs

The operating figures McKesson Corporation reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

McKesson Corporation operating KPIs
KPILatestPeriodChange on a yearRecent periods
North American Pharmaceutical revenue$91.4Bquarter to 30 Sep 2026up 5.6%
Oncology & Multispecialty revenue$15.0Bquarter to 30 Sep 2026up 24.4%
Medical-Surgical Solutions revenue$3.1Bquarter to 30 Sep 2026up 5.1%
Prescription Technology Solutions revenue$1.5Bquarter to 30 Sep 2026up 10.5%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was McKesson Corporation's revenue in fiscal 2026?

$403.4 billion for fiscal year 2026 (the twelve months to 31 Mar 2026), as reported in its annual report.

What was McKesson Corporation's net income in fiscal 2026?

$4.76 billion for fiscal year 2026 (the twelve months to 31 Mar 2026).

What were McKesson Corporation's diluted earnings per share in fiscal 2026?

$38.38 for fiscal year 2026 (the twelve months to 31 Mar 2026).

What is McKesson Corporation's gross margin?

3.6% for fiscal year 2026 (the twelve months to 31 Mar 2026): gross profit divided by revenue.

What is McKesson Corporation's operating margin?

1.5% for fiscal year 2026 (the twelve months to 31 Mar 2026): operating income divided by revenue.

How much free cash flow did McKesson Corporation generate in fiscal 2026?

$5.72 billion for fiscal year 2026 (the twelve months to 31 Mar 2026): operating cash flow less capital expenditure.

Where does McKesson Corporation's revenue come from?

In fiscal 2026, by segment: North American Pharmaceutical $336.7B (83%), Oncology & Multispecialty $48.42B (12%), Medical-Surgical Solutions $11.51B (2.9%), Prescription Technology Solutions $5.80B (1.4%), out of $403.4B in all, as stated in its annual report.

In the terminal

Twenty years of McKesson Corporation's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans